UNIVERSAL HEALTH SERVICES INC (UHS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 7B 14B 21B Q3 '16: 9.6B Q4 '16: 9.8B Q1 '17: 9.9B Q2 '17: 10.1B Q3 '17: 10.2B Q4 '17: 10.4B Q1 '18: 10.5B Q2 '18: 10.6B Q3 '18: 10.7B Q4 '18: 10.8B Q1 '19: 10.9B Q2 '19: 11.1B Q3 '19: 11.2B Q4 '19: 11.4B Q1 '20: 11.4B Q2 '20: 11.3B Q3 '20: 11.4B Q4 '20: 11.6B Q1 '21: 11.7B Q2 '21: 12.2B Q3 '21: 12.5B Q4 '21: 12.6B Q1 '22: 12.9B Q2 '22: 13B Q3 '22: 13.2B Q4 '22: 13.4B Q1 '23: 13.6B Q2 '23: 13.8B Q3 '23: 14B Q4 '23: 14.3B Q1 '24: 14.7B Q2 '24: 15B Q3 '24: 15.4B Q4 '24: 15.8B Q1 '25: 16.1B Q2 '25: 16.5B Q3 '25: 17B Q4 '25: 17.4B Q1 '26: 17.8B Q2 '26: 18.1B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

0 700M 1.4B 2.1B Q3 '16: 1.3B Q4 '16: 1.3B Q1 '17: 1.3B Q2 '17: 1.3B Q3 '17: 1.3B Q4 '17: 1.3B Q1 '18: 1.3B Q2 '18: 1.3B Q3 '18: 1.3B Q4 '18: 1.2B Q1 '19: 1.2B Q2 '19: 1.2B Q3 '19: 1.1B Q4 '19: 1.2B Q1 '20: 1.1B Q2 '20: 1.1B Q3 '20: 1.3B Q4 '20: 1.4B Q1 '21: 1.4B Q2 '21: 1.5B Q3 '21: 1.5B Q4 '21: 1.4B Q1 '22: 1.3B Q2 '22: 1.1B Q3 '22: 1.1B Q4 '22: 1B Q1 '23: 1B Q2 '23: 1.1B Q3 '23: 1.1B Q4 '23: 1.2B Q1 '24: 1.3B Q2 '24: 1.4B Q3 '24: 1.5B Q4 '24: 1.7B Q1 '25: 1.7B Q2 '25: 1.8B Q3 '25: 1.9B Q4 '25: 2B Q1 '26: 2B Q2 '26: 2.1B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income TTM

0 600M 1.2B 1.8B Q3 '16: 702M Q4 '16: 702.4M Q1 '17: 717.7M Q2 '17: 717.5M Q3 '17: 706.9M Q4 '17: 752.3M Q1 '18: 770.1M Q2 '18: 810.7M Q3 '18: 841.2M Q4 '18: 779.7M Q1 '19: 790M Q2 '19: 802.3M Q3 '19: 727.8M Q4 '19: 814.9M Q1 '20: 722.7M Q2 '20: 736.3M Q3 '20: 880.4M Q4 '20: 944M Q1 '21: 1B Q2 '21: 1.1B Q3 '21: 1.1B Q4 '21: 991.6M Q1 '22: 936.4M Q2 '22: 775.5M Q3 '22: 739.9M Q4 '22: 675.6M Q1 '23: 684.8M Q2 '23: 692.1M Q3 '23: 676.2M Q4 '23: 717.8M Q1 '24: 816.5M Q2 '24: 934.4M Q3 '24: 1B Q4 '24: 1.1B Q1 '25: 1.2B Q2 '25: 1.3B Q3 '25: 1.4B Q4 '25: 1.5B Q1 '26: 1.5B Q2 '26: 1.5B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

0 900M 1.8B 2.7B Q3 '16: 1.4B Q4 '16: 1.3B Q1 '17: 1.3B Q2 '17: 1B Q3 '17: 1.1B Q4 '17: 1.2B Q1 '18: 1.2B Q2 '18: 1.3B Q3 '18: 1.3B Q4 '18: 1.3B Q1 '19: 1.3B Q2 '19: 1.3B Q3 '19: 1.4B Q4 '19: 1.4B Q1 '20: 1.5B Q2 '20: 2.2B Q3 '20: 2.6B Q4 '20: 2.4B Q1 '21: 1.9B Q2 '21: 1B Q3 '21: 703.7M Q4 '21: 883.7M Q1 '22: 1.3B Q2 '22: 1.2B Q3 '22: 1B Q4 '22: 996M Q1 '23: 841.3M Q2 '23: 1.2B Q3 '23: 1.1B Q4 '23: 1.3B Q1 '24: 1.4B Q2 '24: 1.7B Q3 '24: 1.9B Q4 '24: 2.1B Q1 '25: 2B Q2 '25: 1.9B Q3 '25: 1.9B Q4 '25: 1.9B Q1 '26: 1.9B Q2 '26: 1.8B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow TTM

-700M 0 700M 1.4B 2.1B Q3 '16: 902.4M Q4 '16: 813.9M Q1 '17: 804.7M Q2 '17: 496.5M Q3 '17: 533.6M Q4 '17: 690.1M Q1 '18: 572.2M Q2 '18: 655.4M Q3 '18: 658.1M Q4 '18: 609.8M Q1 '19: 650.9M Q2 '19: 721.7M Q3 '19: 806.6M Q4 '19: 804.4M Q1 '20: 860.4M Q2 '20: 1.6B Q3 '20: 1.9B Q4 '20: 1.6B Q1 '21: 1.1B Q2 '21: 169.3M Q3 '21: -147M Q4 '21: 28M Q1 '22: 449.1M Q2 '22: 460.9M Q3 '22: 261.6M Q4 '22: 262M Q1 '23: 138.6M Q2 '23: 509M Q3 '23: 411.6M Q4 '23: 524.7M Q1 '24: 590.6M Q2 '24: 833.5M Q3 '24: 956.8M Q4 '24: 1.1B Q1 '25: 1.1B Q2 '25: 901.5M Q3 '25: 968.3M Q4 '25: 849.2M Q1 '26: 912.7M Q2 '26: 845.4M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q2 '13: 99.2M Q3 '13: 99.6M Q1 '14: 100.2M Q2 '14: 100.2M Q3 '14: 101M Q1 '15: 100.6M Q2 '15: 100.9M Q3 '15: 101.2M Q1 '16: 98.9M Q2 '16: 98.4M Q3 '16: 98.3M Q1 '17: 97.4M Q2 '17: 97M Q3 '17: 96M Q1 '18: 94.7M Q2 '18: 94.3M Q3 '18: 93.3M Q1 '19: 91M Q2 '19: 89.2M Q3 '19: 88.4M Q1 '20: 86.5M Q2 '20: 85.1M Q3 '20: 85.2M Q1 '21: 85.8M Q2 '21: 85.6M Q3 '21: 83.7M Q1 '22: 76M Q2 '22: 74.4M Q3 '22: 73.1M Q1 '23: 71.5M Q2 '23: 70.8M Q3 '23: 69.6M Q1 '24: 68.5M Q2 '24: 67.9M Q3 '24: 68.1M Q1 '25: 66M Q2 '25: 65M Q3 '25: 63.7M Q1 '26: 61.7M Q2 '26: 59.9M Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 9.00 18.00 27.00 Q3 '16: 7.10 Q4 '16: 7.14 Q1 '17: 7.33 Q2 '17: 7.35 Q3 '17: 7.28 Q4 '17: 7.81 Q1 '18: 8.05 Q2 '18: 8.53 Q3 '18: 8.90 Q4 '18: 8.29 Q1 '19: 8.50 Q2 '19: 8.77 Q3 '19: 8.03 Q4 '19: 9.12 Q1 '20: 8.19 Q2 '20: 8.48 Q3 '20: 10.20 Q4 '20: 11.01 Q1 '21: 11.80 Q2 '21: 12.64 Q3 '21: 12.42 Q4 '21: 11.81 Q1 '22: 11.40 Q2 '22: 9.81 Q3 '22: 9.71 Q4 '22: 9.15 Q1 '23: 9.41 Q2 '23: 9.63 Q3 '23: 9.53 Q4 '23: 10.24 Q1 '24: 11.78 Q2 '24: 13.62 Q3 '24: 15.02 Q4 '24: 16.82 Q1 '25: 17.80 Q2 '25: 18.97 Q3 '25: 21.03 Q4 '25: 23.12 Q1 '26: 23.97 Q2 '26: 24.52 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.